Chimeric Antigen Receptor (CAR) T-cell Therapy: The Current Success and the Future Promises in Combating Cancer

Marco L. Davila, MD, PhD

Thursday, April 30
8:00 AM – 9:30 AM

Alessandro Villa, DDS, PhD, MPH


This talk highlights the uses of CAR T-cell therapy to treat hematologic neoplasia and other solid tumors.

Learning Objectives

  1. Discuss the basic mechanism of action of CAR T-cell therapy and the current clinical evidence of the efficacy/superiority of CAR T-cell therapy.
  2. Elaborate on CAR T-cell therapy toxicity with emphases on the adverse effects on the head and neck region.
  3. Highlight the future direction of this innovative therapeutic approach.